Skip to main content
MLYS
NASDAQ Life Sciences

Mineralys Reports Pivotal BP Trial Wins and $200M Tanabe License Amendment

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$26.09
Mkt Cap
$2.267B
52W Low
$13.4
52W High
$47.65
52W Position info
95% above low
Off High info
45% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MLYS sits 95% above its 52-week low of $13.4.

Summary

Mineralys reported pivotal Phase 3 and Phase 2 wins showing durable systolic blood pressure drops for lorundrostat, with an open-label extension underway. The company also amended its Tanabe license, paying $200M upfront to remove royalties, with up to $355M in milestone payments tied to commercialization. CMO Dr. Terry Ferguson received equity awards on Aug 10. This follows the June 3 IP buyout and $150M offering; the trial data strengthens the case ahead of the December 2026 FDA decision.

At the time of this announcement, MLYS was trading at $26.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $13.40 to $47.65. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

MLYS - Latest Insights

MLYS
Nov 04, 2026, 5:15 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $16.82
Real-time Price: $15.29 info
Change: -$1.53 (-9%) info
Market Cap: $1.347B info
MLYS
Nov 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.16
Real-time Price: $15.29 info
Change: -$1.87 (-11%) info
Market Cap: $1.347B info
MLYS
Oct 29, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.24
Real-time Price: $15.29 info
Change: -$5.95 (-28%) info
Market Cap: $1.347B info
MLYS
Oct 28, 2026, 7:05 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $21.30
Real-time Price: $15.29 info
Change: -$6.01 (-28%) info
Market Cap: $1.347B info
MLYS
Oct 22, 2026, 6:40 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $21.47
Real-time Price: $15.29 info
Change: -$6.18 (-29%) info
Market Cap: $1.347B info